Cervical cancer remains a global health burden ... This study underscores the feasibility of using metastatic lymph nodes as ideal sources for high-quality TIL production. Attributes such as a ...
Epsilogen, the global leader in the development of immunoglobulin E (IgE) antibodies to treat cancer, today announces that it has commenced a Phase Ib study evaluating MOv18 IgE in patients with ...
StockNews.com initiated coverage on shares of Genocea Biosciences (NASDAQ:GNCA – Free Report) in a research note issued to investors on Tuesday. The brokerage issued a sell rating on the biotechnology ...